Class IIOngoingZ-0040-2026
CORNEAT VISION, LTD. recalls EverPatch+
Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
CORNEAT VISION, LTD.Oct 15, 2025
Drawn from openFDA device enforcement reports. Filter by severity, status, state, year, or manufacturer.
Showing 1–3 of 3 recalls
Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
Reviewed complaints have identified that conjunctival wound dehiscence may result in early exposure of the surgical patch.
Retroactive; Due to complaints, labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of would dehiscence.